Skip to main content

Research Repository

Advanced Search

NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET

van den Bor, Jelle; Bergkamp, Nick D.; Anbuhl, Stephanie M.; Dekker, Françoise; Comez, Dehan; Perez Almeria, Claudia V.; Bosma, Reggie; White, Carl W.; Kilpatrick, Laura E.; Hill, Stephen J.; Siderius, Marco; Smit, Martine J.; Heukers, Raimond

NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET Thumbnail


Authors

Jelle van den Bor

Nick D. Bergkamp

Stephanie M. Anbuhl

Françoise Dekker

Dehan Comez

Claudia V. Perez Almeria

Reggie Bosma

Carl W. White

STEPHEN HILL STEVE.HILL@NOTTINGHAM.AC.UK
Professor of Molecular Pharmacology

Marco Siderius

Martine J. Smit

Raimond Heukers



Abstract

The therapeutic potential of ligands targeting disease-associated membrane proteins is predicted by ligand-receptor binding constants, which can be determined using NanoLuciferase (NanoLuc)-based bioluminescence resonance energy transfer (NanoBRET) methods. However, the broad applicability of these methods is hampered by the restricted availability of fluorescent probes. We describe the use of antibody fragments, like nanobodies, as universal building blocks for fluorescent probes for use in NanoBRET. Our nanobody-NanoBRET (NanoB2) workflow starts with the generation of NanoLuc-tagged receptors and fluorescent nanobodies, enabling homogeneous, real-time monitoring of nanobody-receptor binding. Moreover, NanoB2 facilitates the assessment of receptor binding of unlabeled ligands in competition binding experiments. The broad significance is illustrated by the successful application of NanoB2 to different drug targets (e.g., multiple G protein-coupled receptors [GPCRs] and a receptor tyrosine kinase [RTK]) at distinct therapeutically relevant binding sites (i.e., extracellular and intracellular).

Citation

van den Bor, J., Bergkamp, N. D., Anbuhl, S. M., Dekker, F., Comez, D., Perez Almeria, C. V., …Heukers, R. (2023). NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET. Cell Reports Methods, 3(3), Article 100422. https://doi.org/10.1016/j.crmeth.2023.100422

Journal Article Type Article
Acceptance Date Feb 17, 2023
Online Publication Date Mar 13, 2023
Publication Date Mar 27, 2023
Deposit Date Mar 30, 2023
Publicly Available Date Apr 4, 2023
Journal Cell Reports Methods
Electronic ISSN 2667-2375
Peer Reviewed Peer Reviewed
Volume 3
Issue 3
Article Number 100422
DOI https://doi.org/10.1016/j.crmeth.2023.100422
Public URL https://nottingham-repository.worktribe.com/output/19006199
Publisher URL https://www.sciencedirect.com/science/article/pii/S2667237523000334?via%3Dihub

Files




You might also like



Downloadable Citations